[go: up one dir, main page]

CA2111214A1 - Composition et traitement avec peptides biologiquement actifs ayant des substitutions c-terminales - Google Patents

Composition et traitement avec peptides biologiquement actifs ayant des substitutions c-terminales

Info

Publication number
CA2111214A1
CA2111214A1 CA002111214A CA2111214A CA2111214A1 CA 2111214 A1 CA2111214 A1 CA 2111214A1 CA 002111214 A CA002111214 A CA 002111214A CA 2111214 A CA2111214 A CA 2111214A CA 2111214 A1 CA2111214 A1 CA 2111214A1
Authority
CA
Canada
Prior art keywords
peptide
amino acid
ala
seq
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002111214A
Other languages
English (en)
Inventor
W. Lee Maloy
U. Prasad Kari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Magainin Pharmaceuticals Inc
Original Assignee
Magainin Sciences Inc
Magainin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magainin Sciences Inc, Magainin Pharmaceuticals Inc filed Critical Magainin Sciences Inc
Publication of CA2111214A1 publication Critical patent/CA2111214A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002111214A 1991-06-12 1992-06-01 Composition et traitement avec peptides biologiquement actifs ayant des substitutions c-terminales Abandoned CA2111214A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71371691A 1991-06-12 1991-06-12
US713,716 1991-06-12

Publications (1)

Publication Number Publication Date
CA2111214A1 true CA2111214A1 (fr) 1992-12-23

Family

ID=24867235

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002111214A Abandoned CA2111214A1 (fr) 1991-06-12 1992-06-01 Composition et traitement avec peptides biologiquement actifs ayant des substitutions c-terminales

Country Status (5)

Country Link
EP (1) EP0590044A4 (fr)
JP (1) JPH06511234A (fr)
AU (1) AU2161592A (fr)
CA (1) CA2111214A1 (fr)
WO (1) WO1992022317A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348445B1 (en) 1992-06-01 2002-02-19 Magainin Pharmaceuticals, Inc. Biologically active peptides with reduced toxicity in animals and a method for preparing same
EP0644769A4 (fr) * 1992-06-01 1995-08-09 Magainin Pharma Peptides biologiquement actifs presentant des substitutions n-terminales.
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
US5847047A (en) * 1993-06-22 1998-12-08 E. I. Du Pont De Nemours And Company Antimicrobial composition of a polymer and a peptide forming amphiphilic helices of the magainin-type
FR2734492B1 (fr) * 1995-05-22 1997-06-27 Rossignol Sa Planche de glisse sur neige comportant un dispositif pour le montage d'une fixation d'une chaussure
US6057291A (en) 1995-06-02 2000-05-02 University Of British Columbia Antimicrobial cationic peptides
FR2735983B1 (fr) 1995-06-29 1997-12-05 Centre Nat Rech Scient Peptide permettant de modifier l'activite du systeme immunitaire humain ou animal
WO1997008199A2 (fr) 1995-08-23 1997-03-06 University Of British Columbia Peptides cationiques antimicrobiens et procedes de reconnaissance de ceux-ci
US8283315B2 (en) 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
GB9818938D0 (en) 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
CA2399668A1 (fr) * 2000-02-15 2001-08-23 Ohio University Peptides cationiques presentant une structure secondaire amphipatique de feuillet beta et leurs utilisations
KR101863136B1 (ko) 2008-01-24 2018-05-31 에스퍼란스 파마슈티컬스, 인코포레이티드 용해 도메인 융합 구성물 및 이를 제조하고 사용하는 방법
IL238323B2 (en) 2012-10-30 2023-11-01 Esperance Pharmaceuticals Inc Antibody/drug conjugates and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810777A (en) * 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds
CA2007913A1 (fr) * 1989-01-30 1990-07-30 Michael Zasloff Compose et traitement avec une combinaison de peptides
EP0761684A3 (fr) * 1989-07-07 1997-07-02 Scripps Research Inst Analogues de substitution des peptides de magainine contenant un résidu d'alanine

Also Published As

Publication number Publication date
JPH06511234A (ja) 1994-12-15
AU2161592A (en) 1993-01-12
EP0590044A1 (fr) 1994-04-06
EP0590044A4 (en) 1996-06-12
WO1992022317A1 (fr) 1992-12-23

Similar Documents

Publication Publication Date Title
AU674525B2 (en) Biologically active peptides having N-terminal substitutions
CA2118939A1 (fr) Compositions de peptides amphiphiles biologiquement actives et leur utilisation
CA2111214A1 (fr) Composition et traitement avec peptides biologiquement actifs ayant des substitutions c-terminales
CA2147769A1 (fr) Nouveaux peptides a activite biologique et utilisation de ces molecules
CA2086111A1 (fr) Compositions a base de peptides bioactifs et utilisations
AU652261B2 (en) Novel biologically active peptide compositions and uses therefor
CA2107674A1 (fr) Nouvelles compositions peptidiques et leur utilisation
CA2035959A1 (fr) Compositions peptidiques et leurs utilisations
US5686563A (en) Biologically active peptides having n-terminal substitutions
US5459237A (en) Peptide compositions and uses therefor
CA2125494A1 (fr) Traitement a l'aide d'une composition a base de peptides et d'agents de chelation biologiquement actifs
AU693518B2 (en) Ion-channel forming amphiphilic peptides having n-terminal modifications
CA2294518A1 (fr) Peptides biologiquement actifs a toxicite reduite chez l'animal et procedes d'elaboration
CA2120337A1 (fr) Composition et traitement avec des peptides biologiquement actifs et antibiotique

Legal Events

Date Code Title Description
FZDE Dead